Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



SIMULTANEOUS DETERMINATION OF VALSARTAN, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE IN TABLETS BY NEAR INFRARED

Natana Becker, Gabriela R. Foresti, Willian R. R. Almeida, Karine F. Nicorena, Marco F. Ferrão, Fabiana E. B. Silva.




Abstract

Interval partial least-squares calibration (iPLS) and synergical partial least-squares calibration (siPLS) methods in combination with near infrared spectroscopy coupled with integrating sphere (NIRA) have been developed for simultaneous determination of amlodipine (AML), valsartan (VAL) and hydrochlorothiazide (HCT) in raw material powder mixtures used for production commercial pharmaceutical product (tablets). Variable selection methods (iPLS and siPLS) were applied to select a spectral range that provided the lowest prediction error in comparison to the full-spectrum model. Spectral data were recorded between 10000 and 4000 cm-1 by NIRA and subdivided into 32 intervals. A relative standard error of prediction (RSEP) of 1.27% for VAL, 1.92% for HCT and 5.19% for AML was obtained after selection of better intervals by siPLS. Results shown that multivariate regression model associated to NIRA is a relatively simple, free-solvent and non-destructive procedure that could be applied to the simultaneous determination of AML, VAL and HCT in routine quality control of pharmaceuticals.

Key words: chemometrics, Exforge HCT®, pharmaceutical, quality control.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.